Anti-BCMA therapy in multiple myeloma: a single-center experience

被引：0
|
作者：
Puertas, Borja [1 ]
Fernandez, Adolfo
Jara, Mirian [2 ]
Hernandez, Alberto
Gomez, Sandra
Alejo, Elena
Alonso, David
Maria Navarro, Jose
Rey, Bea
Fonseca, Marta
Avendano, Alejandro
Baile, Monica
Cabero, Almudena
Cabrero, Monica
Lopez, Miriam
Perez, Estefania
Martin, Ana
Lopez, Lucia
Puig, Noemi
Gonzalez, Veronica
Mateos, Maria-Victoria [3 ]
机构：
[1] Univ Hosp Salamanca, Salamanca, Spain
[2] USAL, Salamanca, Spain
[3] Univ Hosp Salamanca, CIC, IBMCC, Salamanca, Spain
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-112
引用
收藏
页码：S96 / S97
页数：2
相关论文
共 50 条
  • [41] Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma
    Garfall, Alfred L.
    Cohen, Adam D.
    Lacey, Simon F.
    Tian, Lifeng
    Hwang, Wei-Ting
    Vogl, Dan T.
    Waxman, Adam
    Lancaster, Eric
    Nelson, Anne Marie
    Ferthio, Regina
    Fesnak, Andrew
    Lamontagne, Anne
    Brennan, Andrea
    Guilliams, Jamie
    Gladney, Whitney Lynn
    Melenhorst, J. Joseph
    Young, Regina M.
    Siegel, Don L.
    Levine, Bruce L.
    Brogdon, Jennifer
    Isaacs, Randi E.
    June, Carl H.
    Milone, Michael C.
    Stadtmauer, Edward A.
    BLOOD, 2019, 134
  • [42] Pseudoprogression in multiple myeloma patients treated with Anti-BCMA CAR-T cells
    Topp, Max
    Schimanski, Sven
    Hornburger, Hannah
    Kadel, Sophie
    Einsele, Hermann
    Rasche, Leo
    Duell, Johannes
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 146 - 146
  • [43] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Wang, Qingming
    Wei, Runhong
    Guo, Shufang
    Min, Chao
    Zhong, Xiong
    Huang, Hui
    Cheng, Zhi
    CANCER GENE THERAPY, 2024, 31 (01) : 108 - 118
  • [44] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Qingming Wang
    Runhong Wei
    Shufang Guo
    Chao Min
    Xiong Zhong
    Hui Huang
    Zhi Cheng
    Cancer Gene Therapy, 2024, 31 : 420 - 426
  • [45] Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
    Stock, Sophia
    Fertig, Luisa
    Gottschlich, Adrian
    Doerr, Janina
    Maerkl, Florian
    Majed, Lina
    Menkhoff, Vivien D.
    Gruenmeier, Ruth
    Rejeski, Kai
    dos Santos, David M. Cordas
    Theurich, Sebastian
    von Bergwelt-Baildon, Michael
    Endres, Stefan
    Subklewe, Marion
    Kobold, Sebastian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (06)
  • [46] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
  • [47] Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma
    Liang, Zhiyu
    Li, Ping
    Kang, Liqing
    Zhou, Lili
    Xu, Yang
    Ye, Shiguang
    Du, Juan
    Li, Bing
    Wang, Yiwen
    Yu, Lei
    Qian, Wenbin
    Liang, Aibin
    BLOOD ADVANCES, 2022, 6 (01) : 293 - 296
  • [48] Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
    Tian-Jiao Guo
    Xiao-Jun Huang
    Lei Wen
    Jin Lu
    中华医学杂志英文版, 2017, 130 (02) : 239 - 241
  • [49] Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
    Guo, Tian-Jiao
    Huang, Xiao-Jun
    Wen, Lei
    Lu, Jin
    CHINESE MEDICAL JOURNAL, 2017, 130 (02) : 239 - 241
  • [50] Acute Lymphoblastic Leukemia Following Multiple Myeloma Therapy: A Single-Center Experience With 9 Patients
    Baran, Natalia
    Babakhanlou, Rodrick
    Sasaki, Koji
    Takahashi, Koichi
    Short, Nicholas
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    Kantarjian, Hagop M.
    Jain, Nitin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S201 - S202
12345